Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type Interaction Map description Network Comparison Type Rank Gene Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2275 to 2324 of 3228 in total 
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pyrroline 5-carboxylate reductase isoform. [source:refseq;acc:nm\_013328]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
487\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5277.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6042.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14505\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pyrroline-5-carboxylate reductase (ec 1.5.1.2) (p5cr) (p5c reductase). [source:swissprot;acc:p32322]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
489\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5281.11\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6044.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14457\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pyruvate carboxylase, mitochondrial precursor (ec 6.4.1.1) (pyruvic carboxylase) (pcb). [source:swissprot;acc:p11498]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
786\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9304.83\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10347.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11204\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pyruvate dehydrogenase e1 component alpha subunit, somatic form, mitochondrial precursor (ec 1.2.4.1) (pdhe1-a type i). [source:swissprot;acc:p08559]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2540\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6672.69\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6827.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0232\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pyruvate dehydrogenase e1 component alpha subunit, testis-specific form, mitochondrial precursor (ec 1.2.4.1) (pdhe1-a type ii). [source:swissprot;acc:p29803]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2537\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6669.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6824.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02327\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pyruvate dehydrogenase e1 component beta subunit, mitochondrial precursor (ec 1.2.4.1) (pdhe1-b). [source:swissprot;acc:p11177]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2450\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6737.15\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6957.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03268\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pyruvate kinase, m1 isozyme (ec 2.7.1.40) (pyruvate kinase muscle isozyme) (cytosolic thyroid hormone-binding protein) (cthbp) (thbp1). [source:swissprot;acc:p14618]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1806\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4783.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5097.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06568\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
quaking isoform 6. [source:sptrembl;acc:q9p0x9]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2224\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5864.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6145.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04786\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
r3h domain (binds single-stranded nucleic acids) containing-like. [source:refseq;acc:nm\_178491]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3132\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
r3h domain protein 1. [source:swissprot;acc:q15032]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2080\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5837.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6162.91\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05577\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rab acceptor 1 (prenylated); prenylated rab acceptor 1. [source:refseq;acc:nm\_006423]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1137\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5790.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6303.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08864\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rab coupling protein; rab-interacting recycling protein; rab effector protein; rab11-family interacting protein 1. [source:refseq;acc:nm\_025151]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1449\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5602.01\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6031.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07659\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rab gdp dissociation inhibitor alpha (rab gdi alpha) (gdi-1) (xap-4) (oligophrenin 2). [source:swissprot;acc:p31150]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3119\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
rab gdp dissociation inhibitor beta (rab gdi beta) (gdi-2). [source:swissprot;acc:p50395]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3193\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
rab geranylgeranyltransferase alpha subunit (ec 2.5.1.-) (rab geranyl- geranyltransferase alpha subunit) (rab gg transferase alpha) (rab ggtase alpha). [source:swissprot;acc:q92696]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3134\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rab3a interacting protein (rabin3)-like 1. [source:refseq;acc:nm\_013401]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1109\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6545.19\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7132.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08979\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rab3a interacting protein isoform alpha 1; rabin3; ssx2 interacting protein. [source:refseq;acc:nm\_022456]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1111\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6540.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7127.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08972\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rabaptin, rab gtpase binding effector protein 1; rabaptin-5; neurocrescin. [source:refseq;acc:nm\_004703]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1737\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5925.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6326.43\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06763\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rac gtpase activating protein 1; gtpase activating protein. [source:refseq;acc:nm\_013277]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1941\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5521.07\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5856.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06083\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rac-alpha serine/threonine kinase (ec 2.7.1.-) (rac-pk-alpha) (protein kinase b) (pkb) (c-akt). [source:swissprot;acc:p31749]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
542\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
3889.27\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4426.74\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.13819\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
rac-beta serine/threonine protein kinase (ec 2.7.1.-) (rac-pk-beta) (protein kinase akt-2) (protein kinase b, beta) (pkb beta). [source:swissprot;acc:p31751]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
545\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
rac-gamma serine/threonine protein kinase (ec 2.7.1.-) (rac-pk-gamma) (protein kinase akt-3) (protein kinase b, gamma) (pkb gamma) (stk-2). [source:swissprot;acc:q9y243]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
544\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rad1 homolog isoform 1; exonuclease homolog rad1; cell cycle checkpoint protein rad1 a/b; rad1-like protein; cell cycle checkpoint protein hrad1; dna repair exonuclease (rec1); dna repair protein rad1; rad1-like dna damage checkpoint protein. [source:refseq;acc:nm\_002853]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2111\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6916.14\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7295.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05481\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rad17 homolog isoform 1; rad17-like protein; cell cycle checkpoint protein (rad17); rf-c activator 1 homolog. [source:refseq;acc:nm\_002873]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1837\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5739.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6108.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06433\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rad50 homolog isoform 1. [source:refseq;acc:nm\_005732]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2601\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7222.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7110.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01566\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rad50-interacting protein 1. [source:refseq;acc:nm\_021930]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
450.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2394.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5.31521\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rad54-like protein; rad54 homolog. [source:refseq;acc:nm\_003579]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1260\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5754.84\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6232.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08306\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rad9 homolog; cell cycle checkpoint control protein; rad9 homolog (s. pombe). [source:refseq;acc:nm\_004584]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2027\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6218.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6575.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05749\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
raf proto-oncogene serine/threonine-protein kinase (ec 2.7.1.-) (raf-1) (c-raf). [source:swissprot;acc:p04049]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
193\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
17756.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
14007.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.26766\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ral guanine nucleotide dissociation stimulator (ralgef) (ralgds). [source:swissprot;acc:q12967]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
267\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
14021.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11523\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.21682\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ral guanine nucleotide dissociation stimulator-like 1 (ralgds-like 1). [source:swissprot;acc:q9nzl6]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
295\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
13261.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11017.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.20368\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ral guanine nucleotide dissociation stimulator-like 2 (ralgds-like factor) (ras-associated protein rab2l). [source:swissprot;acc:o15211]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
217\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
16071.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12886.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.24714\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ral guanine nucleotide exchange factor ralgps1a. [source:refseq;acc:nm\_014636]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2347\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6480.27\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6765.81\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.04406\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
ral-a exchange factor ralgps2. [source:refseq;acc:nm\_152663]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2348\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rala binding protein 1; rala-binding protein. [source:refseq;acc:nm\_006788]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3212\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ran binding protein 11. [source:refseq;acc:nm\_016338]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1032\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6138.91\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6717.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09418\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ran binding protein 3 isoform ranbp3-d; ran-binding protein-3. [source:refseq;acc:nm\_007322]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3202\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ran-binding protein 2 (ranbp2) (nuclear pore complex protein nup358) (nucleoporin nup358) (358 kda nucleoporin) (p270). [source:swissprot;acc:p49792]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2082\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5800.93\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6123.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05559\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
ran-binding protein 2-like 1 isoform 2; sperm membrane protein bs-63; ran-binding protein 2-like 1. [source:refseq;acc:nm\_032260]\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
2083\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5799.84\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6122.18\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05558\vspace{3pt}}}\\\cline{2-4}
&\parbox{\wcB}{\vspace{3pt}\noindent
2084\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5800.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6122.6\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ran-gtp binding protein (fragment). [source:sptrembl;acc:o60518]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
906\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6165.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6783.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10023\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rap1 gtpase-activating protein 1 (rap1gap). [source:swissprot;acc:p47736]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
282\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3119.98\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2579.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.20953\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ras gtpase-activating protein ngap (ras protein activator like 1). [source:swissprot;acc:q9ujf2]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
14\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
398.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1281.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3.21581\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ras suppressor protein 1 (rsu-1) (rsp-1). [source:swissprot;acc:q15404]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1871\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6076.66\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6463.12\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0636\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
ras-gtpase-activating protein binding protein 1 (gap sh3-domain binding protein 1) (g3bp-1). [source:swissprot;acc:q13283]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1872\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
ras-gtpase-activating protein binding protein 2 (gap sh3-domain binding protein 2) (g3bp-2). [source:swissprot;acc:q9un86]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1874\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ras-related c3 botulinum toxin substrate 1 (p21-rac1) (ras-like protein tc25). [source:swissprot;acc:p15154]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1997\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5047.2\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5344.68\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05894\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
ras-related c3 botulinum toxin substrate 2 (p21-rac2) (small g protein) (gx). [source:swissprot;acc:p15153]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2000\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
ras-related c3 botulinum toxin substrate 3 (p21-rac3). [source:swissprot;acc:o14658]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1998\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ras-related gtp binding a; ras-related gtp-binding protein. [source:refseq;acc:nm\_006570]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
319\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
20911\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
24908.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.19117\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/